BSI members are encouraged to submit abstracts before this date - it's a fantastic opportunity to showcase your research to an audience of over 2,000 rheumatology health professionals at the UK's
leading rheumatology event.
Not exact matches
«Our findings show that a specific genetic marker (known as allele * 2 of the HS1, 2 A enhancer region) influences not just disease activity in RA patients, but also response to therapy in the early stages of their disease,» said
lead investigator Dr Gabriele Di Sante of the Institute of
Rheumatology and Related Sciences, Catholic University of the Sacred Heart, Rome, Italy.
However, no study has specifically assessed the risk of ASD in offspring of mothers with lupus, explains Evelyne Vinet, MD, FRCPC; assistant professor, Department of
Rheumatology; McGill University Health Centre, Montreal; and
lead investigator in the study.
Professor Cyrus Cooper, Professor of
Rheumatology and Director of the MRC Lifecourse Epidemiology Unit, University of Southampton, added: «This study forms part of a larger programme of work addressing risk factors for fracture across the lifecourse, and demonstrates the importance of the University of Southampton and MRC Lifecourse Epidemiology Unit in
leading large, UK wide analyses on the internationally
leading UK Clinical Practice Research Datalink dataset.
Lead guideline author Caroline Gordon, a lupus expert and Professor of
Rheumatology at the University of Birmingham, said: «Lupus can affect any part of the body and can be difficult to diagnose and treat.
Professor Nicholas Harvey, Professor of
Rheumatology and Clinical Epidemiology at the MRC Lifecourse Epidemiology Unit, University of Southampton,
led the study with Dr Elizabeth Curtis, Academic Clinical Fellow in
Rheumatology.
«We were able to convert antibodies that cause autoimmune disease into anti-inflammatory antibodies by specifically modifying the sugars attached to the antibodies,» says Robert Anthony, PhD, of the Center for Immunology and Inflammatory Diseases in the MGH Division of
Rheumatology, Allergy and Immunology, who
led the study.
Loyola Medicine orthopaedic surgeon Dane Salazar, MD, a former Air Force orthopaedic surgeon, is
lead author of the study, published in the Journal of Orthopedics and
Rheumatology.
Dr. Brady is one of the foremost authorities on properly diagnosing and treating fibromyalgia, has been featured in top popular media including Dr. Oz, ELLE and NPR; has published in
leading peer - reviewed medical journals including Open Journal of
Rheumatology and Autoimmune Disease and Integrative Medicine: A Clinician's Journal.
I have worked with
leading pharmaceutical organizations promoting products to a variety of specialties including pain management, allergy, orthopedics,
rheumatology, cardiology, and primary care.